SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $994 | +98.0% | 36,067 | +116.0% | 0.07% | +102.8% |
| Q2 2023 | $502 | +9.4% | 16,695 | +31.7% | 0.04% | +5.9% |
| Q1 2023 | $459 | +2.2% | 12,675 | +0.6% | 0.03% | -2.9% |
| Q4 2022 | $449 | -99.9% | 12,601 | +3.0% | 0.04% | +2.9% |
| Q3 2022 | $414,000 | +22.1% | 12,236 | +4.5% | 0.03% | +30.8% |
| Q2 2022 | $339,000 | -12.6% | 11,712 | -2.5% | 0.03% | +8.3% |
| Q1 2022 | $388,000 | +21.6% | 12,013 | +9.8% | 0.02% | +33.3% |
| Q4 2021 | $319,000 | +17.7% | 10,941 | +7.7% | 0.02% | +12.5% |
| Q3 2021 | $271,000 | -7.5% | 10,161 | +6.6% | 0.02% | -11.1% |
| Q2 2021 | $293,000 | +39.5% | 9,531 | +18.9% | 0.02% | +28.6% |
| Q1 2021 | $210,000 | – | 8,019 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |